OpenFilings

Oruka Therapeutics, Inc.

Form10-K

Report Period2024-12-31

Date Filed2025-03-06

Time Filed16:02:05

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

ANNUAL REPORT
DESCRIPTION OF SECURITIES
FORM OF PRE-FUNDED WARRANT, DATED AUGUST 29, 2024
AMENDED AND RESTATED EMPLOYMENT LETTER AGREEMENT BY AND BETWEEN ORUKA THERAPEUTI
AMENDED AND RESTATED EMPLOYMENT LETTER AGREEMENT BY AND BETWEEN ORUKA THERAPEUTI
FORM OF INDEMNIFICATION AGREEMENT
NON-EMPLOYEE DIRECTORS COMPENSATION PROGRAM
IL-17 LICENSE AGREEMENT BY AND BETWEEN PARAGON THERAPEUTICS, INC. AND ORUKA THER
IL-23 LICENSE AGREEMENT BY AND BETWEEN PARAGON THERAPEUTICS, INC. AND ORUKA THER
CELL LINE LICENSE AGREEMENT BY AND BETWEEN WUXI BIOLOGICS IRELAND LIMITED AND OR
AMENDMENT NO. 1 TO THE CELL LINE LICENSE AGREEMENT BY AND BETWEEN WUXI BIOLOGICS
INSIDER TRADING POLICY
LIST OF SUBSIDIARIES OF THE REGISTRANT
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
CERTIFICATION
CERTIFICATION
CERTIFICATION
INCENTIVE COMPENSATION CLAWBACK POLICY
Filing on SEC Edgar